COVID-19 Intervention Actions: Providing Medication-Assisted Treatment for Opioid Use Disorder [open pdf - 177KB]
From the Overview: "This document summarizes recent guidance for providing medication-assisted treatment (MAT) for opioid use disorder during the COVID-19 [coronavirus disease 2019] outbreak. This summary was compiled by ASTHO [Association of State and Territorial Health Officials] staff at a specific point in time and will be updated periodically as new information is available. The COVID-19 pandemic comes at a time when the United States is still grappling with the opioid epidemic. Along with concern for populations traditionally vulnerable to infectious disease, those who use substances are now considered particularly vulnerable to COVID-19 (especially if their substance use is through smoking). In order to provide continuity of care and reduce the severity of the potential intersection of these two epidemics, federal and state agencies have begun to relax restrictions around take-home medications like methadone and explore telemedicine options."
Association of State and Territorial Health Officials. Posted here with permission. Documents are for personal use only and not for commercial profit.
Association of State and Territorial Health Officials: https://www.astho.org/